Disease: Familial hyperlipoproteinemia type 4
- "Lipoid" Macular Edema in Familial Hypertriglyceridemia and Retinal Dystrophy
- 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance
- A Case of Type V Hyperlipoproteinemia Resistant to Insulin Treatment
- Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study
- Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010-2020: a cross-sectional study
- Apheresis: What Should a Clinician Know?
- Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study
- Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia)
- Familial hypertriglyceridemia/polygenic hypertrigliceridemia
- Frameshift coding sequence variants in the LPL gene: identification of two novel events and exploration of the genotype-phenotype relationship for variants reported to date
- In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia
- Influence of lipid metabolism disorders on venous thrombosis risk
- Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia
- Lipoprotein(a) as Part of the Diagnosis of Clinical Familial Hypercholesterolemia
- Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study
- Management of Patients with Type V Hyperlipoproteinemia: An Uncommon Phenotype of Dyslipidemia with Chylomicronemia and Severe Hypertriglyceridemia
- Management strategy and novel ophthalmological findings in neonatal severe hypertriglyceridemia: a case report and literature review
- Metformin Affects Cardiac Arachidonic Acid Metabolism and Cardiac Lipid Metabolite Storage in a Prediabetic Rat Model
- Modelling the potential long-term survival benefit of evinacumab treatment vs. standard of care in patients with homozygous familial hypercholesterolaemia
- Update lipidology : Evidence-based treatment of dyslipidemia